Skip to content
PubMed This is a summary of 76 peer-reviewed journal articles Updated
Genetics

Neurofibromatosis Type 1 (NF1): A Comprehensive Guide

At a Glance

Neurofibromatosis Type 1 (NF1) is a variable, multisystem genetic condition that affects how cells grow. This comprehensive guide helps patients and parents understand NF1 symptoms, the 2021 diagnostic criteria, tumor management, and modern treatments like MEK inhibitors to effectively coordinate lifelong care.

Neurofibromatosis Type 1 (NF1) is a complex, lifelong genetic condition that affects how cells grow and communicate, leading to a wide variety of symptoms across the body. Whether you are an adult who has just been diagnosed, or a parent navigating this new reality for your child, feeling overwhelmed is completely normal.

This guide is designed to empower you. It translates the medical science into clear, actionable information so you can understand the condition, anticipate what lies ahead, and build a medical team that will provide the best possible care.

The journey with NF1 is different for everyone. Because it is a multisystem condition with high variability, no two cases look exactly alike. While this unpredictability can be frightening, knowing the facts, the risks, and the available treatments puts you back in control.

How to Use This Guide

We have broken down the essential information you need into five detailed sections. You can read them in order, or jump to the topic that is most relevant to you right now:

Knowledge is your most powerful tool. By understanding the biology of NF1 and knowing the right questions to ask, you can actively advocate for yourself or your child at every medical appointment.

Common questions in this guide

What is Neurofibromatosis Type 1 (NF1)?
NF1 is a lifelong genetic condition that alters how cells grow and communicate. It is a multisystem disorder that can cause a wide variety of symptoms, including skin changes, bone issues, and the growth of tumors.
How is NF1 diagnosed?
NF1 is diagnosed using the revised 2021 diagnostic criteria. These updated guidelines combine physical examinations, looking for specific clinical signs like skin changes, with modern genetic testing to confirm the diagnosis.
What are the current treatments for NF1?
While there is no cure for NF1, treatments are available to manage symptoms. Options include surgery for certain tumors and breakthrough targeted therapies, such as MEK inhibitors, which help control tumor growth.
Who should manage my NF1 care?
Because NF1 affects many different body systems, care requires a multidisciplinary team. It is important to establish a primary doctor to act as a 'quarterback' who coordinates your monitoring and treatment with various specialists throughout your life.
Will my child's NF1 symptoms be the same as someone else's?
No, the journey with NF1 is unique for each person. The condition is highly variable, meaning no two cases look exactly alike, and symptoms can evolve significantly from infancy into adulthood.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Who will serve as the primary 'quarterback' or care coordinator for my/my child's NF1 management?
  2. 2.How familiar is your clinic with the 2021 revised diagnostic criteria for NF1, including the addition of genetic testing?
  3. 3.What is the best way to reach the care team if we notice a sudden change in a symptom or a new 'red flag'?
  4. 4.Can you outline what a realistic multidisciplinary care team looks like for someone exactly in my or my child's current stage of life?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

This guide is for educational purposes only and does not replace professional medical advice. Always consult your geneticist, neurologist, or coordinated care team for personal medical decisions regarding Neurofibromatosis Type 1.

Get notified when new evidence is published on Neurofibromatosis type 1.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.